Abstract

Weight loss (WL) differences between isocaloric high-carbohydrate and high-fat diets are generally small; however, individual WL varies within diet groups. Genotype patterns may modify diet effects, with carbohydrate-responsive genotypes losing more weight on high-carbohydrate diets (and vice versa for fat-responsive genotypes). We investigated whether 12-week WL (kg, primary outcome) differs between genotype-concordant and genotype-discordant diets. In this 12-week single-center WL trial, 145 participants with overweight/obesity were identified a priori as fat-responders or carbohydrate-responders based on their combined genotypes at ten genetic variants and randomized to a high-fat (n = 73) or high-carbohydrate diet (n = 72), yielding 4 groups: (1) fat-responders receiving high-fat diet, (2) fat-responders receiving high-carbohydrate diet, (3) carbohydrate-responders receiving high-fat diet, (4) carbohydrate-responders receiving high-carbohydrate diet. Dietitians delivered the WL intervention via 12 weekly diet-specific small group sessions. Outcome assessors were blind to diet assignment and genotype patterns. We included 122 participants (54.4 [SD:13.2] years, BMI 34.9 [SD:5.1] kg/m2, 84% women) in the analyses. Twelve-week WL did not differ between the genotype-concordant (−5.3 kg [SD:1.0]) and genotype-discordant diets (−4.8 kg [SD:1.1]; adjusted difference: −0.6 kg [95% CI: −2.1,0.9], p = 0.50). With the current ability to genotype participants as fat- or carbohydrate-responders, evidence does not support greater WL on genotype-concordant diets. ClinicalTrials identifier: NCT04145466.

Genotype patterns may modify diet effects on weight loss, with greater weight loss on genotype-concordant diets. Here, the authors show that with the current ability to genotype participants as fat- or carbohydrate-responders, evidence does not support greater weight loss on genotype-concordant diets.

Details

Title
The Personalized Nutrition Study (POINTS): evaluation of a genetically informed weight loss approach, a Randomized Clinical Trial
Author
Höchsmann, Christoph 1   VIAFID ORCID Logo  ; Yang, Shengping 2 ; Ordovás, José M. 3   VIAFID ORCID Logo  ; Dorling, James L. 4   VIAFID ORCID Logo  ; Champagne, Catherine M. 2   VIAFID ORCID Logo  ; Apolzan, John W. 2   VIAFID ORCID Logo  ; Greenway, Frank L. 2   VIAFID ORCID Logo  ; Cardel, Michelle I. 5 ; Foster, Gary D. 6   VIAFID ORCID Logo  ; Martin, Corby K. 2   VIAFID ORCID Logo 

 Technical University of Munich, Department of Health and Sport Sciences, TUM School of Medicine and Health, Munich, Germany (GRID:grid.6936.a) (ISNI:0000 0001 2322 2966); Pennington Biomedical Research Center, Baton Rouge, USA (GRID:grid.250514.7) (ISNI:0000 0001 2159 6024) 
 Pennington Biomedical Research Center, Baton Rouge, USA (GRID:grid.250514.7) (ISNI:0000 0001 2159 6024) 
 Tufts University, Boston, USA (GRID:grid.429997.8) (ISNI:0000 0004 1936 7531) 
 University of Glasgow, Human Nutrition, School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life of Sciences, Glasgow, UK (GRID:grid.8756.c) (ISNI:0000 0001 2193 314X) 
 WW International, Inc., New York, USA (GRID:grid.518870.3) (ISNI:0000 0004 0609 8045); University of Florida College of Medicine, Department of Health Outcomes and Biomedical Informatics, Gainesville, USA (GRID:grid.15276.37) (ISNI:0000 0004 1936 8091) 
 WW International, Inc., New York, USA (GRID:grid.518870.3) (ISNI:0000 0004 0609 8045); Center for Weight and Eating Disorders, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972) 
Pages
6321
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2874656835
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.